Literature DB >> 8392605

Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit.

T Tsurumi1, A Kobayashi, K Tamai, T Daikoku, R Kurachi, Y Nishiyama.   

Abstract

A recombinant baculovirus containing the complete sequence for the Epstein-Barr virus (EBV) DNA polymerase catalytic subunit, BALF5 gene product, under the control of the baculovirus polyhedrin promoter was constructed. Insect cells infected with the recombinant virus produced a protein of 110 kDa, recognized by anti-BALF5 protein-specific polyclonal antibody. The expressed EBV DNA polymerase catalytic polypeptide was purified from the cytosolic fraction of the recombinant virus-infected insect cells. The purified protein exhibited both DNA polymerase and 3'-to-5' exonuclease activities, which were neutralized by the anti-BALF5 protein-specific antibody. These results indicate that the 3'-to-5' exonuclease activity associated with the EBV DNA polymerase (T. Tsurumi, Virology 182:376-381, 1991) is an inherent feature of the polymerase catalytic polypeptide. The DNA polymerase and the exonuclease activities of the EBV DNA polymerase catalytic subunit were sensitive to ammonium sulfate in contrast to those of the polymerase complex purified from EBV-producing lymphoblastoid cells, which were stimulated by salt. Furthermore, the template-primer preference for the polymerase catalytic subunit was different from that for the polymerase complex. These observations strongly suggest that the presence of EBV DNA polymerase accessory protein, BMRF1 gene product, does influence the enzymatic properties of EBV DNA polymerase catalytic subunit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392605      PMCID: PMC237850     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  Structure and function of the bacteriophage T4 DNA polymerase holoenzyme.

Authors:  M C Young; M K Reddy; P H von Hippel
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

2.  Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.

Authors:  B Kallin; L Sternås; A K Saemundssen; J Luka; H Jörnvall; B Eriksson; P Z Tao; M T Nilsson; G Klein
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Primer terminus recognition and highly processive replication by Epstein-Barr virus DNA polymerase.

Authors:  T Tsurumi
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

4.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

5.  Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system.

Authors:  T Tsurumi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Authors:  J Yates; N Warren; D Reisman; B Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Baculovirus induction of a DNA polymerase.

Authors:  L K Miller; J E Jewell; D Browne
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

8.  Properties of herpes simplex virus DNA polymerase and characterization of its associated exonuclease activity.

Authors:  K W Knopf
Journal:  Eur J Biochem       Date:  1979-07

9.  trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbol ester-treated Epstein-Barr virus-carrying cells.

Authors:  J F Chiou; J K Li; Y C Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more
  20 in total

1.  The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex.

Authors:  K Fujii; N Yokoyama; T Kiyono; K Kuzushima; M Homma; Y Nishiyama; M Fujita; T Tsurumi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Architecture of replication compartments formed during Epstein-Barr virus lytic replication.

Authors:  Tohru Daikoku; Ayumi Kudoh; Masatoshi Fujita; Yutaka Sugaya; Hiroki Isomura; Noriko Shirata; Tatsuya Tsurumi
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Spatiotemporally different DNA repair systems participate in Epstein-Barr virus genome maturation.

Authors:  Atsuko Sugimoto; Teru Kanda; Yoriko Yamashita; Takayuki Murata; Shinichi Saito; Daisuke Kawashima; Hiroki Isomura; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

5.  Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Authors:  Q Zhang; Y Hong; D Dorsky; E Holley-Guthrie; S Zalani; N A Elshiekh; A Kiehl; T Le; S Kenney
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

7.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

8.  Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition.

Authors:  Ya-Fang Chiu; Arthur U Sugden; Bill Sugden
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

9.  Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.

Authors:  Dongsheng Xu; Tricia Coleman; Jun Zhang; Ashley Fagot; Catherine Kotalik; Lingjun Zhao; Pankaj Trivedi; Clinton Jones; Luwen Zhang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 10.  Replication of Epstein-Barr viral DNA.

Authors:  Wolfgang Hammerschmidt; Bill Sugden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.